CA
PTCT icon

Commerzbank Aktiengesellschaft’s PTC Therapeutics PTCT Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22,518
Closed -$246K – 970
2016
Q4 		$246K Sell
22,518
-1,393
-6% -$14.6K ﹤0.01% 846
2016
Q3 		$335K Buy
23,911
+1,423
+6% +$11.6K 0.01% 683
2016
Q2 		$158 Buy
+22,488
New +$165K ﹤0.01% 944
2015
Q4 		– Sell
-25,088
Closed -$670K – 1180
2015
Q3 		$670K Buy
25,088
+5,032
+25% +$215K 0.01% 686
2015
Q2 		$965K Buy
+20,056
New +$1.17M 0.01% 822

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Commerzbank Aktiengesellschaft's PTCT Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of PTC Therapeutics (PTCT) in Q1 2017, closing a stake of 22,518 shares — an estimated $246K sold.

Commerzbank Aktiengesellschaft first reported a position in PTCT in Q2 2015 and held it in 5 quarters. The position peaked at $965K in Q2 2015. 115 funds tracked by Wall St. Rank hold PTCT as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining PTC Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 22,518 PTC Therapeutics shares in Q1 2017, an estimated $246K.
  • Commerzbank Aktiengesellschaft first reported a position in PTC Therapeutics in Q2 2015 and held it in 5 quarters.
  • Commerzbank Aktiengesellschaft's PTC Therapeutics position peaked at $965K in Q2 2015.
  • 115 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.